Insulin sensitizers in treatment of nonalcoholic fatty liver disease: Systematic review

doi:10.3748/wjg.v12.i48.7826

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 48

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2821)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

375

HTML

2137

Figures (1-3)

168

Tables (1-1)

141

Sum=2821

Dec 28, 2006 (publication date) through Jul 28, 2024

Times Cited of This Article

Times Cited (17)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Dec 28, 2006; 12(48): 7826-7831
Published online Dec 28, 2006. doi: 10.3748/wjg.v12.i48.7826

Full Size Figure Download Figure

Figure 3 ¹Only seven patients in the treatment group. Information about the control group is not available; ²This study reported anemia as an adverse effect, but numerical data are not available. NR: not reported; NA: not applied; HOMA: homeostatic model assessment.

Citation: Chavez-Tapia NC, Barrientos-Gutierrez T, Tellez-Ávila FI, Sánchez-Ávila F, Montaño-Reyes MA, Uribe M. Insulin sensitizers in treatment of nonalcoholic fatty liver disease: Systematic review. World J Gastroenterol 2006; 12(48): 7826-7831
URL: https://www.wjgnet.com/1007-9327/full/v12/i48/7826.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i48.7826